Smith Group Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-76,410
| Closed | -$789K | – | 466 |
|
|
2015
Q4 | $789K | Buy |
+76,410
| New | +$789K | 0.02% | 185 |
|
|
2014
Q1 | – | Sell |
-291,983
| Closed | -$2.22M | – | 408 |
|
|
2013
Q4 | $2.22M | Sell |
291,983
-1,613
| -0.5% | -$12.3K | 0.08% | 156 |
|
|
2013
Q3 | $2.14M | Sell |
293,596
-8,600
| -3% | -$62.6K | 0.09% | 155 |
|
|
2013
Q2 | $468K | Buy |
+302,196
| New | +$468K | 0.02% | 209 |
|